Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Even after more than 50 MMPl-icenses we still have the same share price trouble

Had they not paid the dividends they might have put that much more cash into ARS; we might be in a similar position.



That still would have given RG $16 million more to work with



Share
New Message
Please login to post a reply